Leading brokerage Axis Direct has highlighted three prominent Indian stocks – Hindustan Aeronautics Ltd (HAL), Piramal Pharma Ltd, and Aditya Birla Capital Ltd – as strong 'buy' recommendations for traders. The analysis, provided ahead of Wednesday's trading session by Rajesh Palviya, Head of Research at Axis Direct, points to significant technical breakouts and bullish indicators across all three companies.
Piramal Pharma
Piramal Pharma Ltd has decisively broken past its multiple resistance zone of Rs 182 over the past two months, supported by substantial trading volumes. This breakout, combined with the confirmation of an inverse head & shoulders pattern, signals strong bullish sentiment. The stock is currently trading above its 20, 50, 100, and 200-day Simple Moving Averages (SMAs), which are all trending upwards, further reinforcing the positive outlook. Daily, weekly, and monthly Relative Strength Index (RSI) readings remain bullish, indicating increasing buying momentum.
- Recommendation: Buy
- Target Price: Rs 195-205
- Stop Loss: Rs 175
Hindustan Aeronautics (HAL)
Hindustan Aeronautics Ltd (HAL) has also experienced a significant breakout, surpassing its one-month multiple resistance zone at Rs 4,535 on a closing basis with huge volumes. The daily Bollinger Band buy signal further confirms this increased momentum. Similar to Piramal Pharma, HAL is trading strongly above its 20, 50, 100, and 200-day SMAs, all of which are rising. Bullish RSI readings across daily, weekly, and monthly charts underscore the stock's growing strength.
- Recommendation: Buy
- Target Price: Rs 4,700-4,800
- Stop Loss: Rs 4,500
Aditya Birla Capital
Aditya Birla Capital Ltd (AB Capital) is currently demonstrating a strong uptrend across all timeframes, indicating robust bullish sentiment. The stock consistently forms higher tops and bottoms on its daily and weekly charts. It trades comfortably above its 20, 50, 100, and 200-day SMAs, which are all moving upwards, confirming the bullish trend. AB Capital has also broken out of a multi-week down-sloping trendline at the Rs 407 level, signaling a positive shift. Its daily, weekly, and monthly RSI readings remain bullish, reflecting sustained strength.
- Recommendation: Buy
- Target Price: Rs 420-435
- Stop Loss: Rs 395
Disclaimer: This article provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.